title: Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety.
abstract: We established mouse models of extremes in trait anxiety, which are based on selective breeding for low vs. normal vs. high open-arm exploration on the elevated plus-maze. Genetically selected low anxiety-related behavior (LAB) coincided with hyperactivity in the home cage. Given the fact that several psychiatric disorders such as schizophrenia, mania, and attention deficit hyperactivity disorder (ADHD) share hyperactivity symptom, we systematically examined LAB mice with respect to unique and overlapping endophenotypes of the three diseases. To this end Venn diagrams were used as an instrument for discrimination of possible models. We arranged the endophenotypes in Venn diagrams and translated them into different behavioral tests. LAB mice showed elevated levels of locomotion in the open field (OF) test with deficits in habituation, compared to mice bred for normal (NAB) and high anxiety-related behavior (HAB). Cross-breeding of hypoactive HAB and hyperactive LAB mice resulted in offspring showing a low level of locomotion comparable to HAB mice, indicating that the HAB alleles are dominant over LAB alleles in determining the level of locomotion. In a holeboard test, LAB mice spent less time in hole exploration, as shown in patients with schizophrenia and ADHD; however, LAB mice displayed no impairments in social interaction and prepulse inhibition (PPI), implying a unlikelihood of LAB as an animal model of schizophrenia. Although LAB mice displayed hyperarousal, active coping styles, and cognitive deficits, symptoms shared by mania and ADHD, they failed to reveal the classic manic endophenotypes, such as increased hedonia and object interaction. The neuroleptic haloperidol reduced locomotor activity in all mouse lines. The mood stabilizer lithium and the psychostimulant amphetamine, in contrast, selectively reduced hyperactivity in LAB mice. Based on the behavioral and pharmacological profiles, LAB mice are suggested as a novel rodent model of ADHD-like symptoms.
authors: Department of Neuronal Plasticity, Max Planck Institute of Psychiatry Munich, Germany.
authors: Yi-Chun
authors: YC
authors: Yen
authors: Elmira
authors: E
authors: Anderzhanova
authors: Mirjam
authors: M
authors: Bunck
authors: Julia
authors: J
authors: Schuller
authors: Rainer
authors: R
authors: Landgraf
authors: Carsten T
authors: CT
authors: Wotjak
keywords: ADHD; LAB; amphetamine; hyperactivity; selective breeding
references: Behav Brain Res. 2005 Mar 7;158(1):97-107
references: 15680198
references: PLoS One. 2009;4(4):e5129
references: 19357765
references: Trends Ecol Evol. 1992 Sep;7(9):307-10
references: 21236041
references: Front Neurosci. 2013 May 29;7:82
references: 23754970
references: Learn Mem. 2005 Jul-Aug;12(4):407-13
references: 16077019
references: Behav Neurosci. 2005 Oct;119(5):1339-52
references: 16300440
references: J Psychiatry Neurosci. 2006 Sep;31(5):326-32
references: 16951735
references: Front Behav Neurosci. 2010 Nov 01;4:169
references: 21103015
references: Behav Genet. 2001 Jul;31(4):371-82
references: 11720123
references: Psychiatr Clin North Am. 1992 Mar;15(1):1-27
references: 1347936
references: J Psychiatr Res. 2010 Jul;44(10):629-39
references: 20060129
references: Neurosci Biobehav Rev. 2010 Jul;34(8):1256-66
references: 20381522
references: Neurobiol Learn Mem. 2012 Jul;98(1):56-65
references: 22579802
references: Behav Neurosci. 2002 Jun;116(3):464-71
references: 12049327
references: Pharmacol Biochem Behav. 2008 Sep;90(3):331-8
references: 18445506
references: Trends Pharmacol Sci. 2005 May;26(5):237-43
references: 15860370
references: Genes Brain Behav. 2009 Oct;8(7):685-98
references: 19563475
references: Int J Neuropsychopharmacol. 2012 Feb;15(1):41-53
references: 21439107
references: Pharmacol Biochem Behav. 2007 Oct;87(4):426-33
references: 17599397
references: Soc Neurosci. 2011;6(2):156-68
references: 20661836
references: Neuropsychopharmacology. 2010 Jan;35(2):388-400
references: 19794408
references: Behav Brain Res. 2002 Mar 10;130(1-2):65-71
references: 11864719
references: Behav Brain Res. 2001 Jan 8;118(1):95-105
references: 11163638
references: Front Behav Neurosci. 2012 Dec 27;6:87
references: 23293591
references: Neurochem Int. 2012 Jan;60(1):55-67
references: 22080157
references: Behav Genet. 2004 May;34(3):309-18
references: 14990869
references: Psychiatry Res. 1987 Dec;22(4):283-9
references: 3501597
references: Genes Brain Behav. 2013 Jun;12(4):424-37
references: 23433259
references: Neurosci Biobehav Rev. 2007;31(1):89-102
references: 16934871
references: Ann Neurol. 2000 Oct;48(4):556-66
references: 11026439
references: Curr Opin Psychiatry. 2010 Jan;23(1):1-7
references: 19770771
references: Biol Psychiatry. 1992 Nov 15;32(10):939-43
references: 1467378
references: Psychopharmacology (Berl). 2013 Jun;227(4):741-9
references: 23397052
references: Behav Brain Res. 2004 Jul 9;152(2):351-60
references: 15196803
references: Neurosci Biobehav Rev. 2008 Oct;32(8):1544-68
references: 18619487
references: Genes Brain Behav. 2004 Oct;3(5):303-14
references: 15344923
references: Arch Neurol. 1978 Jul;35(7):463-9
references: 566540
references: Brain Res. 2011 Oct 24;1419:34-45
references: 21925645
references: Physiol Behav. 1995 Aug;58(2):315-21
references: 7568435
references: Neuropeptides. 2007 Jun;41(3):145-63
references: 17420046
references: Exp Clin Psychopharmacol. 2010 Apr;18(2):184-201
references: 20384430
references: Nat Neurosci. 2002 Jan;5(1):13-4
references: 11731802
references: JAMA. 2000 Feb 23;283(8):1025-30
references: 10697062
references: Front Behav Neurosci. 2011 Aug 17;5:49
references: 21887137
references: Am J Psychiatry. 2012 Sep;169(9):982-90
references: 22952076
references: Behav Brain Res. 2009 Dec 28;205(2):544-9
references: 19703496
references: Behav Genet. 2003 Sep;33(5):503-11
references: 14574127
references: Genes Brain Behav. 2004 Oct;3(5):287-302
references: 15344922
references: Experientia. 1991 Oct 15;47(10):1008-19
references: 1936199
references: J Neurosci. 2005 Apr 27;25(17):4375-84
references: 15858064
references: J Pharmacol Exp Ther. 2002 Jun;301(3):1097-102
references: 12023542
references: Horm Behav. 2007 Jan;51(1):11-9
references: 16935287
references: Arch Gen Psychiatry. 2009 Oct;66(10):1072-80
references: 19805697
references: Nat Neurosci. 2010 Oct;13(10):1161-9
references: 20877280
references: Behav Pharmacol. 2005 May;16(3):171-80
references: 15864072
references: Behav Neurosci. 2011 Jun;125(3):282-96
references: 21480691